MediWound Competitors and Similar CompaniesClear all
MediWound's competitors and similar companies include Immatics and Ansun BioPharma.
 MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Ansun BioPharma Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses. | |
Founding Date | Founding Date 2001 | Founding Date N/A | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations San Diego, US HQ |
Employees | Employees 111 | Employees 29723% increase | Employees 22 |
Valuation ($) | Valuation ($) 196.3 m | Valuation ($) 1.1 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $17m (FY, 2025) | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $13.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $4.1m (FY, 2025) | Gross profit €53m (FY, 2025) | Gross profit N/A |
Net income | Net income ($23.9m) (FY, 2025) | Net income (€196.4m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 267.3m | Total funding raised $ 183.9m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyAnsun BioPharma
HQ
San Diego, US
Employees
22
Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses.
View company